Cargando…

Triple Negative Breast Cancer: An Analysis of the Subtypes and the Effects of Menopausal Status on Invasive Breast Cancer

Background: Triple negative breast cancer (TNBC) is a subtype of breast cancer which lacks hormone receptor (HR) expression and HER2 gene amplification and is the most aggressive subtype, with a heterogeneous genetic profile. The aim of this retrospective study was to evaluate the clinical significa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishimura, Reiki, Osako, Tomofumi, Okumura, Yasuhiro, Nakano, Masahiro, Otsuka, Hiroko, Fujisue, Mamiko, Arima, Nobuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103495/ https://www.ncbi.nlm.nih.gov/pubmed/35566456 http://dx.doi.org/10.3390/jcm11092331

Ejemplares similares

An evaluation of lymphovascular invasion in relation to biology and prognosis according to subtypes in invasive breast cancer
por: Nishimura, Reiki, et al.
Publicado: (2022)

Clinical Significance of CK19 Negative Breast Cancer
por: Fujisue, Mamiko, et al.
Publicado: (2012)

The importance of tissue handling of surgically removed breast cancer for an accurate assessment of the Ki-67 index
por: Arima, Nobuyuki, et al.
Publicado: (2016)

Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study
por: Tashima, Rumiko, et al.
Publicado: (2015)

Pertuzumab for the treatment of patients with human epidermal growth factor receptor 2-positive breast cancer in Japan
por: OSAKO, TOMOFUMI, et al.
Publicado: (2015)

Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis
por: Nishimura, Reiki, et al.
Publicado: (2011)

BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer
por: Mori, Hitomi, et al.
Publicado: (2016)

The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancer
por: Mori, Hitomi, et al.
Publicado: (2017)

Microsatellite instability in Japanese female patients with triple-negative breast cancer
por: Kurata, Kanako, et al.
Publicado: (2020)

T-bet(+) lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer
por: Mori, Hitomi, et al.
Publicado: (2019)

Granzyme B Expression in the Tumor Microenvironment as a Prognostic Biomarker for Patients with Triple-Negative Breast Cancer
por: Mizoguchi, Kimihisa, et al.
Publicado: (2023)

Identification of Cancer-Associated Fibroblast Subtype of Triple-Negative Breast Cancer
por: Wang, Maoli, et al.
Publicado: (2022)

TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
por: Chen, Xi, et al.
Publicado: (2012)

Triple-negative breast cancer molecular subtyping and treatment progress
por: Yin, Li, et al.
Publicado: (2020)

Molecular stratification within triple-negative breast cancer subtypes
por: Wang, Dong-Yu, et al.
Publicado: (2019)

Molecular subtypes and precision treatment of triple-negative breast cancer
por: Zhao, Shen, et al.
Publicado: (2020)

Reassessment of Reliability and Reproducibility for Triple-Negative Breast Cancer Subtyping
por: Yu, Xinjian, et al.
Publicado: (2022)

Prognostic role of GPER/Ezrin in triple-negative breast cancer is associated with menopausal status
por: Ye, Shuang, et al.
Publicado: (2019)

Future of Triple Negative Breast Cancer: Can Immunotherapy Treat This Deadly Subtype of Breast Cancer?
por: Salimi, Mona
Publicado: (2018)

Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer
por: Ensenyat-Mendez, Miquel, et al.
Publicado: (2021)

Reverse phase protein array identification of triple-negative breast cancer subtypes and comparison with mRNA molecular subtypes
por: Masuda, Hiroko, et al.
Publicado: (2017)

Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers
por: Masuda, Hiroko, et al.
Publicado: (2013)

Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype
por: Harano, Kenichi, et al.
Publicado: (2018)

Metabolic Syndrome and the Risk of Breast Cancer and Subtypes by Race, Menopause and BMI
por: Dibaba, Daniel T., et al.
Publicado: (2018)

Optical Redox Imaging Differentiates Triple-Negative Breast Cancer Subtypes
por: Jiang, Jinxia, et al.
Publicado: (2021)

Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis
por: Cserni, Gábor, et al.
Publicado: (2021)

Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype
por: Funakoshi, Yohei, et al.
Publicado: (2019)

Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?
por: Le Du, Fanny, et al.
Publicado: (2015)

Molecular subtypes of triple-negative breast cancer in women of different race and ethnicity
por: Ding, Yuan Chun, et al.
Publicado: (2019)

Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype
por: Giuli, M. V., et al.
Publicado: (2019)

Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
por: Jézéquel, Pascal, et al.
Publicado: (2019)

Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
por: Hill, David P., et al.
Publicado: (2019)

Radiomics in Triple Negative Breast Cancer: New Horizons in an Aggressive Subtype of the Disease
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications
por: Asleh, Karama, et al.
Publicado: (2022)

Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancer
por: Pu, Shengyu, et al.
Publicado: (2022)

Rare subtypes of triple negative breast cancer: Current understanding and future directions
por: Thomas, Alexandra, et al.
Publicado: (2023)

Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer
por: Tong, Ling, et al.
Publicado: (2023)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Family history of breast and ovarian cancer and triple negative subtype in hispanic/latina women
por: Anderson, Kristin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_109m2n2vq0gjfv5gsglakanpb1